Effects of 17 beta-estradiol on osteogenic differentiation of rat primary cultured bone marrow mesenchymal stem cells

Han Na,Kou Yu-hui,Wang Tian-bing,Yin Xiao-feng,He Pei-ying,Zhang Pei-xun
DOI: https://doi.org/10.3969/j.issn.1673-8225.2012.10.003
2012-01-01
Abstract:BACKGROUND:The estrogen receptor exists in bone marrow mesenchymal stem cells and estrogen promotes bone formation by regulating the proliferation and differentiation of bone marrow mesenchymal stem cells.OBJECTIVE:To explore the effects of 17β-estradiol on the osteogenic differentiation of bone marrow mesenchymal stem cells(MSCs) and the underlying mechanism.METHODS:MSCs were separated,purified,cultured and expanded.Different concentrations of 17β-estradiol was administrated to MSCs for some period.The level of type I collagen in culture medium was detected by Elisa method,and the expression of Runx2 mRNA and protein was analyzed by RT-PCR or Western blotting methods,respectively.RESULTS:Compared with the control group,type I collagen expression in the MSCs was significantly increased on the 5th day after administration of 0.001,0.01,0.1 nmol/L 17β estradiol(P < 0.05) and it maintained high expression on the 7th day(P < 0.05).Runx2 mRNA expression increased in a dose-dependent manner on the 5th and 7th days after administration of 17 β-estradiol(P < 0.05).These findings suggest that 17β-estradiol can induce the osteogenic differentiation of MSCs,which occurs possibly by upregulation of Runx2 expression.
What problem does this paper attempt to address?